Prospective data suggest DecisionDx-Melanoma may help refine SLNB decisions and identify recurrence risk beyond conventional staging.
Related to this article
Falk G. Bechara, MD, discusses long-term tunnel control, structural damage, and the evolving role of biologics and surgery in HS care.
New dermatology research explores hidden steroids in OTC products, infant eczema, melanoma prevention, cutaneous lymphoma, and pediatric AD.
This week’s review highlights pediatric oral minoxidil guidance, alopecia areata imaging, inherited skin disorder growth patterns, total-body photography, and radiofrequency microneedling for rosacea.
Advertisement
Advertisement
Trending on Dermatology Times
1
Topical vs Oral JAK Inhibitors for Vitiligo: How to Choose as Systemic Options Advance
2
Chronic Hand Eczema Linked to Lost Productivity and Lower Quality of Life
3
First-in-Class Oral PKM2 Modulator Shows Early Efficacy in Atopic Dermatitis
4
Alopecia Areata Is a Medical Disease: Treatment Options and Defining Severity
5